GlassScriptPhysician profile
Madhav Lavu
NPI 1447459193
$13,393.43
in general payments reported to CMS, 2019-2025
18 companies · $7,046 in 2025
The $7,046 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,471 · 2020: $215 · 2021: $1,337 · 2022: $1,212 · 2023: $633 · 2024: $479 · 2025: $7,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,256 · Travel and Lodging: $3,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,256.28 |
| Travel and Lodging | $3,901.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,004.14 | 2021-2025 | Micra, Pulseselect, Aurora Ev-Icd Mri Surescan |
| Biotronik INC. | $4,077.59 | 2021-2025 | Amvia Edge, Selectra, Acticor 7 Vr-T Dx |
| Abbott Laboratories | $2,471.42 | 2019-2025 | Aveir, Ensite Precision, Tacticath Ablation Catheter, Sensor Enabled |
| Boston Scientific Corporation | $1,038.94 | 2019-2020 | |
| Medtronic Vascular, INC. | $216.16 | 2019-2020 | |
| Atricure, INC. | $195.35 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.15 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $64.69 | 2019 | |
| Amarin Pharma, INC. | $64.08 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $33.20 | 2019 | |
| Sanofi-Aventis U.S. LLC | $33.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.09 | 2020 | |
| Grifols USA, LLC | $24.22 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.82 | 2019 | |
| Chiesi USA, INC. | $14.21 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.80 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.05 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madhav Lavu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.